Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealiusPHCRF 52 Days Inventory is 55.16 as of Dec. 2025, which is 9% above its 10-year median of 50.70. GuruFocus rates PHCRF with a GF Score™ of 52/100 and a GF Value™ of $2.23. The stock has 7 warning signs investors should review. Among 179 Medical Diagnostics & Research companies, Healius ranks better than 54.75% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Healius's Average Total Inventories for the
six
months ended in Dec. 2025 was $21.3 Mil. Healius's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $70.6 Mil.
Hence, Healius's Days Inventory for the
six
months ended in Dec. 2025 was 55.16.
The historical rank and industry rank for Healius's Days Inventory or its related term are showing as below:
PHCRF'
s Days Inventory Range Over the Past 10 Years
Min: 39.68 Med: 50.7 Max: 66.9
Current: 55.88
During the past 13 years, Healius's highest Days Inventory was 66.90. The lowest was 39.68. And the median was 50.70.
PHCRF's Days Inventory is ranked better than 54.75% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.04
vs PHCRF: 55.88
Healius's Days Inventory
declined
from Dec. 2024 (55.94) to Dec. 2025 (55.16).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Healius's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Healius's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
Healius (OTCPK:PHCRF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Healius's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Healius's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Healius Days Inventory Related Terms
Healius Days Inventory Historical Data
* Premium members only.
The historical data trend for Healius's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHCRF vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Healius's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healius Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Healius's Days Inventory distribution charts can be found below:
* The bar in red indicates where Healius's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healius (PHCRF) has a Days Inventory of 55.16 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Healius and its competitors. This is near median its historical median of 50.70. Over the past decade, Healius' Days Inventory has ranged from 39.68 to 66.90. According to the industry distribution chart, Healius ranks #81 out of 179 companies in the Medical Diagnostics & Research industry, placing it in the top 45.3%.
Is Healius' Days Inventory too high?
Healius' current Days Inventory of 55.16 is near median its 10-year median of 50.70. Over the past 10 years, this metric has ranged from a low of 39.68 to a high of 66.90. The Medical Diagnostics & Research industry median Days Inventory is 65.04. Healius' value of 55.16 is 15.2% below this industry median. Based on the distribution chart, Healius ranks #81 out of 179 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Healius has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Healius' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Healius ranks #81 out of 179 companies for Days Inventory. This puts Healius in the upper half of its industry. The industry median Days Inventory is 65.04. Healius' value of 55.16 is 15.2% below this benchmark. Historically, Healius' own Days Inventory has ranged from 39.68 to 66.90 over the past decade. While the company's 10-year median is 50.70 vs. the industry median of 65.04, Healius has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 65.04, based on 179 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healius's current Days Inventory of 55.16 is 15.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Healius and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 65.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healius's current Days Inventory is 55.16, which is near median its own 10-year median of 50.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Healius (PHCRF) has a current Days Inventory of 55.16. The stock's GF Value™ is $2.23, compared to a current price of $0.84 — trading 62.3% below its estimated fair value. The current Days Inventory is 55.16, which is near median its 10-year median of 50.70 and 15.2% below the Medical Diagnostics & Research industry median of 65.04. Healius' overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Healius (PHCRF), the current Days Inventory is 55.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healius (PHCRF) Overvalued in 2026?
Based on GuruFocus' analysis, Healius stock appears to be undervalued.
The current stock price of $0.84 is trading 62.3% below its estimated GF Value™ of $2.23.
Key valuation signals for PHCRF:
Days Inventory: 55.16 (near median its 10-year median of 50.70)
GF Value™: $2.23 vs. price of $0.84 (62.3% below fair value)
Industry Position: 15.2% below the Medical Diagnostics & Research median (#81 of 179)
No single metric tells the full story. See the PHCRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
52GF Score
Get the complete analysis for PHCRF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHCRF has been successfully added to your 
